Switch to:
More From Other Websites
Novogen (NVGN) Stock Rises Today After Announcing Brain Cancer Treatment Collaboration Apr 17 2015
7:01 am Novogen announces it signs an MOU with the Feinstein Institute for Medical Research to... Apr 17 2015
Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer Apr 16 2015
Novagen (NVGN) Stock Spiked Today on Melanoma Treatment Study Results Apr 09 2015
Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma Apr 08 2015
Novogen Engages Leading US Investor Relations Firm Apr 01 2015
Novogen shares surge on drug data Mar 30 2015
Yale University and Novogen Release Data on Cantrixil Mode of Action Mar 29 2015
Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study Mar 18 2015
Sky News, Helen Dalley interviews Dr Graham Kelly Mar 09 2015
Cantrixil Data to be Presented at Two Major Conferences Mar 06 2015
Novogen Makes Big Step In Fighting Brain Cancer Mar 04 2015
US Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells Mar 04 2015
Novogen to Present at AusBiotech "Broker Meets Biotech" Event Mar 02 2015
Novogen to Present at SACHS Cancer Bio Partnering & Investment Forum Feb 22 2015
Novogen Investor Briefing Well Received Feb 19 2015
Novogen Lodges Key Super-benzopyran Patent Feb 11 2015
Novogen to present at BIO & CEO Investor Conference 9th & 10th February, 2015 Feb 03 2015
Novogen Soars 50% Following Brain Stem Cell News Jan 15 2015
Novogen Announces Important Discovery in Regenerative Medicine Program Jan 15 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK